Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-28T15:00:48.889Z Has data issue: false hasContentIssue false
  • English
  • Français

Activity modulation of microbial enzymes by llama (Lama glama) heavy-chain polyclonal antibodies during in vivo immune responses

Published online by Cambridge University Press:  30 September 2011

A. Ferrari ,
F. S. Weill ,
M. L. Paz ,
E. M. Cela ,
D. H. González Maglio  and
J. Leoni
A. Ferrari*
Affiliation:
Immunology Section, Department of Microbiology, Immunology and Biotechnology, Pharmacy and Biochemistry School, University of Buenos Aires, Buenos Aires, Argentina
F. S. Weill
Affiliation:
Immunology Section, Department of Microbiology, Immunology and Biotechnology, Pharmacy and Biochemistry School, University of Buenos Aires, Buenos Aires, Argentina
M. L. Paz
Affiliation:
Immunology Section, Department of Microbiology, Immunology and Biotechnology, Pharmacy and Biochemistry School, University of Buenos Aires, Buenos Aires, Argentina
E. M. Cela
Affiliation:
Immunology Section, Department of Microbiology, Immunology and Biotechnology, Pharmacy and Biochemistry School, University of Buenos Aires, Buenos Aires, Argentina
D. H. González Maglio
Affiliation:
Immunology Section, Department of Microbiology, Immunology and Biotechnology, Pharmacy and Biochemistry School, University of Buenos Aires, Buenos Aires, Argentina
J. Leoni
Affiliation:
Immunology Section, Department of Microbiology, Immunology and Biotechnology, Pharmacy and Biochemistry School, University of Buenos Aires, Buenos Aires, Argentina
Get access

Abstract

Since they were first described in 1993, it was found that recombinant variable fragments (rVHHs) of heavy-chain antibodies (HCAbs) from Camelidae have unusual biophysical properties, as well as a special ability to interact with epitopes that are cryptic for conventional Abs. It has been assumed that in vivo raised polyclonal HCAbs (pHCAbs) should behave in a similar manner than rVHHs; however, this assumption has not been tested sufficiently. Furthermore, our own preliminary work on a single serum sample from a llama immunized with a β-lactamase, has suggested that pHCAbs have no special ability to down-modulate catalytic activity. In this work, we further explored the interaction of pHCAbs from four llamas raised against two microbial enzymes and analyzed it within a short and a long immunization plan. The relative contribution of pHCAbs to serum titer was found to be low compared with that of the most abundant conventional subisotype (IgG1), during the whole immunization schedule. Furthermore, pHCAbs not only failed to inhibit the enzymes, but also activated one of them. Altogether, these results suggest that raising high titer inhibitory HCAbs is not a straightforward strategy – neither as a biotechnological strategy nor in the biological context of an immune response against infection – as raising inhibitory rVHHs.

Keywords

heavy-chain antibodiescamelidsenzyme modulationβ-lactamaseaspartic protease
Type
Full Paper
Information
animal , Volume 6 , Issue 3: 61th EAAP Annual Meeting, 2010, Heraklion, Greece: 10th International Workshop on Biology of Lactation in Farm Animals (BOLFA) and Session “Evolution of mammary gland and milk secretion: consequences for lactation in farm animals” , 27 January 2012 , pp. 510 - 517
Copyright
Copyright © The Animal Consortium 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bendicho, S, Martí, G, Hernández, T, Martín, O 2002. Determination of proteolytic activity in different milk systems. Food Chemistry 79, 245–249.CrossRefGoogle Scholar
Cook, DAN, Samarasekara, CL, Wagstaff, SC, Kinne, J, Wernery, U, Harrison, RA 2010. Analysis of camelid IgG for antivenom development: immunoreactivity and preclinical neutralization of venom-induced pathology by IgG subclasses, and the effect of heat treatment. Toxicon 56, 596–603.CrossRefGoogle ScholarPubMed
De Genst, E, Silence, K, Decanniere, K, Conrath, K, Loris, R, Kinne, J, Muyldermans, S, Wyns, L 2006. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proceedings of the National Academy of Sciences, USA 103, 4586–4591.CrossRefGoogle ScholarPubMed
De Simone, EA, Saccodossi, N, Ferrari, A, Leoni, J 2008. Development of ELISAs for the measurement of IgM and IgG subclasses in sera from llamas (Lama glama) and assessment of the humoral immune response against different antigens. Veterinary Immunology and Immunopathology 126, 64–73.CrossRefGoogle ScholarPubMed
De Simone, EA, Saccodossi, N, Ferrari, A, Leoni, L, Leoni, J 2005. Immunochemical analysis of IgG subclasses and IgM in South American camelids. Small Ruminant Research 64, 2–9.CrossRefGoogle Scholar
Doña, V, Urrutia, M, Bayardo, M, Alzogaray, V, Goldbaum, FA, Chirdo, F 2010. Single domain antibodies are specially suited for quantitative determination of gliadins under denaturing conditions. Journal of Agricultural and Food Chemistry 58, 918–926.CrossRefGoogle ScholarPubMed
Ewert, S, Cambillau, C, Conrath, K, Plückthun, A 2002. Biophysical properties of camelid VHH domains compared to those of human VH3 domains. Biochemistry 41, 3628–3636.CrossRefGoogle ScholarPubMed
Ferrari, A, Rodríguez, MM, Power, P, Weill, FS, De Simone, EA, Gutkind, G, Leoni, J 2007. Immunobiological role of llama heavy-chain antibodies against a bacterial β-lactamase. Veterinary Immunology and Immunopathology 117, 173–182.CrossRefGoogle ScholarPubMed
Hamers-Casterman, C, Atarhouch, S, Muyldermans, S, Robinson, G, Hamers, C, Songa, EB, Bendahman, N, Hamers, R 1993. Naturally occurring antibodies devoid of light chains. Nature 363, 446–448.CrossRefGoogle ScholarPubMed
Lauwereys, M, Ghahroudi, MA, Desmyter, A, Kinne, J, Hölzer, W, De Genst, E, Wyns, L, Muyldermans, S 1998. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO Journal 17, 3512–3520.CrossRefGoogle ScholarPubMed
Martin, F, Volpari, C, Steinkuhler, C, Dimasi, N, Brunetti, M, Biasiol, G, Altamara, S, Cortese, R, De Francesco, R, Sollazzo, M 1997. Affinity selection of a camelized VH domain antibody inhibitor of hepatitis C virus NS3 protease. Protein Engineering 10, 607–614.CrossRefGoogle ScholarPubMed
Matagne, A, Frère, JM 1995. Contribution of mutant analysis to the understanding of enzyme catalysis: the case of class A β-lactamases. Biochimica et Biophysica Acta 1246, 109–127.CrossRefGoogle Scholar
Muyldermans, S 2001. Single domain camel antibodies: current status. Journal of Biotechnology 74, 277–302.Google ScholarPubMed
Muyldermans, S 2009. Camelid immunoglobulins and nanobody technology. Veterinary Immunology and Immunopathology 128, 178–183.CrossRefGoogle ScholarPubMed
Nguyen, VK, Su, C, Muyldermans, S, van der Loo, W 2002. Heavy-chain antibodies in camelidae; a case of evolutionary innovation. Immunogenetics 54, 39–47.Google ScholarPubMed
Page, MI, Laws, AP 1998. The mechanism of catalysis and the inhibition of β-lactamases. Chemical Communications 1609–1617.CrossRefGoogle Scholar
Pérez, JMJ, Renisio, JG, Prompers, JJ, van Platernik, CJ, Cambillau, C, Darbon, H, Frenken, LGJ 2001. Thermal unfolding of a llama antibody fragment: a two-state reversible process. Biochemistry 40, 74–83.CrossRefGoogle ScholarPubMed
Power, P, Galleni, M, Ayala, JA, Gutkind, G 2005. Biochemical and molecular characterization of three new variants of AmpC β-lactamases from Morganella morganii. Antimicrobial Agents and Chemotherapy 50, 962–967.CrossRefGoogle Scholar
Saerens, D, Ghassabeh, GH, Muyldermans, S 2008. Single-domain antibodies as building blocks for novel therapeutics. Current Opinion in Pharmacology 8, 600–608.CrossRefGoogle ScholarPubMed
Saerens, D, Kinne, J, Bosmans, E, Wernery, U, Muyldermans, S, Conrath, K 2004. Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen. Journal of Biological Chemistry 279, 51965–51972.CrossRefGoogle ScholarPubMed
Su, C, Nguyen, VK, Nei, M 2002. Adaptive evolution of variable region genes encoding an unusual type of immunoglobulin in camelids. Molecular Biology and Evolution 19, 205–215.CrossRefGoogle ScholarPubMed
Stijlemans, B, Caljon, G, Natesan, SKA, Saerens, D, Conrath, K, Pérez-Morga, D, Skepper, JN, Nikolaou, A, Brys, L, Pays, E, Magez, S, Field, MC, De Baetselier, P, Muyldermans, S 2011. High affinity nanobodies against the trypanosome brucei VSG are potent trypanolytic agents that block endocytosis. PLoS Pathog 7, e1002072.CrossRefGoogle ScholarPubMed
van der Linden, R, de Geus, B, Stok, W, Bos, W, van Wassenaar, D, Verrips, T, Frenken, L 2000. Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama. Journal of Immunological Methods 240, 185–195.CrossRefGoogle ScholarPubMed
van der Linden, RHJ, Frenken, LGJ, de Geus, B, Harmsen, MM, Ruuls, RC, Stok, W, de Ron, L, Wilson, S, Davis, P, Verrips, CT 1999. Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochimica et Biophysica Acta 1431, 37–46.CrossRefGoogle ScholarPubMed
Yang, J, Teplyakov, A, Quail, JW 1997. Crystal structure of the aspartic proteinase from Rhizomucor miehei at 2.15 A Resolution. Journal of Molecular Biology 268, 449–459.CrossRefGoogle ScholarPubMed